- Home
- GOVX vs SINT Comparison
GOVX vs SINT Comparison
Compare GOVX & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- SINT
- Stock Information
- Founded
- GOVX 2001
- SINT 1996
- Country
- GOVX United States
- SINT United States
- Employees
- GOVX N/A
- SINT N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- GOVX Health Care
- SINT Health Care
- Exchange
- GOVX Nasdaq
- SINT Nasdaq
- Market Cap
- GOVX 7.6M
- SINT 8.3M
- IPO Year
- GOVX N/A
- SINT 2014
- Fundamental
- Price
- GOVX $0.68
- SINT $4.30
- Analyst Decision
- GOVX Strong Buy
- SINT Strong Buy
- Analyst Count
- GOVX 3
- SINT 1
- Target Price
- GOVX $10.67
- SINT $28.00
- AVG Volume (30 Days)
- GOVX 690.2K
- SINT 2.2M
- Earning Date
- GOVX 11-11-2025
- SINT 11-11-2025
- Dividend Yield
- GOVX N/A
- SINT N/A
- EPS Growth
- GOVX N/A
- SINT N/A
- EPS
- GOVX N/A
- SINT N/A
- Revenue
- GOVX $6,143,044.00
- SINT $1,861,000.00
- Revenue This Year
- GOVX N/A
- SINT N/A
- Revenue Next Year
- GOVX N/A
- SINT $87.50
- P/E Ratio
- GOVX N/A
- SINT N/A
- Revenue Growth
- GOVX 1943.07
- SINT N/A
- 52 Week Low
- GOVX $0.43
- SINT $1.71
- 52 Week High
- GOVX $3.88
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- GOVX 41.08
- SINT 54.45
- Support Level
- GOVX $0.65
- SINT $4.20
- Resistance Level
- GOVX $0.73
- SINT $4.73
- Average True Range (ATR)
- GOVX 0.04
- SINT 0.70
- MACD
- GOVX -0.00
- SINT -0.04
- Stochastic Oscillator
- GOVX 21.28
- SINT 24.47
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.